The presentation and diagnosis of coronary allograft vasculopathy in pediatric heart transplant recipients

Congenital Heart Disease

Volumn 7, Issue 4, 2012, Pages 302-311

  Jeewa, Aamir ^a   Dreyer, William J ^a   Kearney, Debra L ^a   Denfield, Susan W ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Angiography; Coronary Allograft Vasculopathy; Heart Transplant

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; DOBUTAMINE; GADOLINIUM; TROPONIN I;

ABDOMINAL PAIN; ANGIOCARDIOGRAPHY; ARM PAIN; ARTERIAL WALL THICKNESS; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL FEATURE; CORONARY FLOW RESERVE; DOBUTAMINE STRESS ECHOCARDIOGRAM; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; GRAFT FAILURE; GRAFT RECIPIENT; HEART HEMODYNAMICS; HEART INFARCTION; HEART MUSCLE BIOPSY; HEART MUSCLE ISCHEMIA; HEART TRANSPLANTATION; HOLTER MONITORING; HUMAN; INTRAVASCULAR ULTRASOUND; MICROVASCULATURE; MULTIDETECTOR COMPUTED TOMOGRAPHY; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROBABILITY; Q WAVE; QT DISPERSION; QT PROLONGATION; SENSITIVITY AND SPECIFICITY; ST SEGMENT; SUDDEN DEATH; THORAX PAIN; TISSUE DOPPLER IMAGING;

CARDIAC CATHETERIZATION; CHILD; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAPHY; HEART TRANSPLANTATION; HUMANS;

EID: 84864317299     PISSN: 1747079X     EISSN: 17470803     Source Type: Journal    
DOI: 10.1111/j.1747-0803.2012.00656.x     Document Type: Article

References (63)

1. Kirk R, Edwards LB, Kucheryavaya AY, etal. The registry of the international society for heart and lung transplantation: fourteenth pediatric heart transplantation report-2011. J Heart Lung Transplant. 2011;30:1095-1103.
2. Kocik M, Malek I, Janek B, Zelizko M, Pirk J. Risk factors for the development of coronary artery disease of a grafted heart as detected very early after orthotopic heart transplantation. Transpl Int. 2007;20:666-674.
3. Bae JH, Rihal CS, Edwards BS, etal. Association of angiotensin-converting enzyme inhibitors and serum lipids with plaque regression in cardiac allograft vasculopathy. Transplantation. 2006;82:1108-1111.
4. Costanzo-Nordin MR. Cardiac allograft vasculopathy: relationship with acute cellular rejection and histocompatibility. J Heart Lung Transplant. 1992;11:S90-S103.
5. Shiba N, Chan MC, Kwok BW, Valantine HA, Robbins RC, Hunt SA. Analysis of survivors more than 10 years after heart transplantation in the cyclosporine era: Stanford experience. J Heart Lung Transplant. 2004;23:155-164.
6. Hussain T, Burch M, Fenton MJ, etal. Positive pretransplantation cytomegalovirus serology is a risk factor for cardiac allograft vasculopathy in children. Circulation. 2007;115:1798-1805.
7. Webber SA. Cytomegalovirus infection and cardiac allograft vasculopathy in children. Circulation. 2007;115:1701-1702.
8. Pahl E, Naftel DC, Kuhn MA, etal. The impact and outcome of transplant coronary artery disease in a pediatric population: a 9-year multi-institutional study. J Heart Lung Transplant. 2005;24:645-651.
9. Buendia-Fuentes F, Almenar L, Ruiz C, etal. Sympathetic reinnervation 1 year after heart transplantation, assessed using iodine-123 metaiodobenzylguanidine imaging. Transplant Proc. 2011;43:2247-2248.
10. Price JF, Towbin JA, Dreyer WJ, etal. Symptom complex is associated with transplant coronary artery disease and sudden death/resuscitated sudden death in pediatric heart transplant recipients. J Heart Lung Transplant. 2005;24:1798-1803.
11. Chantranuwat C, Blakey JD, Kobashigawa JA, etal. Sudden, unexpected death in cardiac transplant recipients: an autopsy study. J Heart Lung Transplant. 2004;23:683-689.
12. Gao SZ, Hunt SA, Wiederhold V, Schroeder JS. Characteristics of serial electrocardiograms in heart transplant recipients. Am Heart J. 1991;122:771-774.
13. Nytroen K, Myers J, Chan KN, Geiran OR, Gullestad L. Chronotropic responses to exercise in heart transplant recipients: 1-yr follow-up. Am J Phys Med Rehabil. 2011;90:579-588.
14. Gao SZ, Schroeder JS, Hunt SA, Billingham ME, Valantine HA, Stinson EB. Acute myocardial infarction in cardiac transplant recipients. Am J Cardiol. 1989;64:1093-1097.
15. Ali A, Mehra MR, Malik FS, Uber PA, Ventura HO. Insights into ventricular repolarization abnormalities in cardiac allograft vasculopathy. Am J Cardiol. 2001;87:367-368, A10.
16. Kolasa MW, Lee JC, Atwood JE, Marcus RR, Eckart RE. Relation of QTc duration heterogeneity to mortality following orthotopic heart transplantation. Am J Cardiol. 2005;95:431-432.
17. Vrtovec B, Radovancevic R, Thomas CD, Yazdabakhsh AP, Smart FW, Radovancevic B. Prognostic value of the QTc interval after cardiac transplantation. J Heart Lung Transplant. 2006;25:29-35.
18. Vande Kappelle RP, Gambetta K, Deal BJ, Backer CL, Sullivan CL, Pahl E. Late sinus and atrial tachycardia after pediatric heart transplantation might predict poor outcome. Pediatr Cardiol. 2010;31:643-649.
19. LaPage MJ, Rhee EK, Canter CE. Tachyarrhythmias after pediatric heart transplantation. J Heart Lung Transplant. 2010;29:273-277.
20. Cannon BC, Denfield SW, Friedman RA, etal. Late pacemaker requirement after pediatric orthotopic heart transplantation may predict the presence of transplant coronary artery disease. J Heart Lung Transplant. 2004;23:67-71.
21. Gullestad L, Ross H, Myers J, etal. Importance of decreased heart rate in predicting transplant coronary artery disease. Clin Transplant. 1997;11:628-632.
22. Grinstead WC, Smart FW, Pratt CM, etal. Sudden death caused by bradycardia and asystole in a heart transplant patient with coronary arteriopathy. J Heart Lung Transplant. 1991;10:931-936.
23. Kertesz NJ, Towbin JA, Clunie S, etal. Long-term follow-up of arrhythmias in pediatric orthotopic heart transplant recipients: incidence and correlation with rejection. J Heart Lung Transplant. 2003;22:889-893.
24. Arora S, Gullestad L, Wergeland R, etal. Probrain natriuretic peptide and C-reactive protein as markers of acute rejection, allograft vasculopathy, and mortality in heart transplantation. Transplantation. 2007;83:1308-1315.
25. Martinez-Dolz L, Almenar L, Reganon E, etal. Follow-up study on the utility of von Willebrand factor levels in the diagnosis of cardiac allograft vasculopathy. J Heart Lung Transplant. 2008;27:760-766.
26. Labarrere CA, Nelson DR, Cox CJ, Pitts D, Kirlin P, Halbrook H. Cardiac-specific troponin I levels and risk of coronary artery disease and graft failure following heart transplantation. JAMA. 2000;284:457-464.
27. Pethig K, Heublein B, Kutschka I, Haverich A. Systemic inflammatory response in cardiac allograft vasculopathy: high-sensitive C-reactive protein is associated with progressive luminal obstruction. Circulation. 2000;102:III233-III236.
28. Mehra MR. Contemporary concepts in prevention and treatment of cardiac allograft vasculopathy. Am J Transplant. 2006;6:1248-1256.
29. Mehra MR, Uber PA, Potluri S, Ventura HO, Scott RL, Park MH. Usefulness of an elevated B-type natriuretic peptide to predict allograft failure, cardiac allograft vasculopathy, and survival after heart transplantation. Am J Cardiol. 2004;94:454-458.
30. Park MH, Scott RL, Uber PA, Ventura HO, Mehra MR. Usefulness of B-type natriuretic peptide as a predictor of treatment outcome in pulmonary arterial hypertension. Congest Heart Fail. 2004;10:221-225.
31. Rossano JW, Denfield SW, Kim JJ, etal. B-type natriuretic peptide levels late after transplant predict graft survival in pediatric heart transplant patients. J Heart Lung Transplant. 2010;29:385-386.
32. Claudius I, Lan YT, Chang RK, Wetzel GT, Alejos J. Usefulness of B-type natriuretic peptide as a noninvasive screening tool for cardiac allograft pathology in pediatric heart transplant recipients. Am J Cardiol. 2003;92:1368-1370.
33. Asante-Korang A, Fickey M, Boucek MM, Boucek RJ, Jr. Diastolic performance assessed by tissue Doppler after pediatric heart transplantation. J Heart Lung Transplant. 2004;23:865-872.
34. Eroglu E, D'Hooge J, Sutherland GR, etal. Quantitative dobutamine stress echocardiography for the early detection of cardiac allograft vasculopathy in heart transplant recipients. Heart. 2008;94:e3.
35. Dandel M, Hummel M, Muller J, etal. Reliability of tissue Doppler wall motion monitoring after heart transplantation for replacement of invasive routine screenings by optimally timed cardiac biopsies and catheterizations. Circulation. 2001;104:I184-I191.
36. Fyfe DA, Ketchum D, Lewis R, etal. Tissue Doppler imaging detects severely abnormal myocardial velocities that identify children with pre-terminal cardiac graft failure after heart transplantation. J Heart Lung Transplant. 2006;25:510-517.
37. Steinberg EH, Madmon L, Patel CP, Sedlis SP, Kronzon I, Cohen JL. Long-term prognostic significance of dobutamine echocardiography in patients with suspected coronary artery disease: results of a 5-year follow-up study. J Am Coll Cardiol. 1997;29:969-973.
38. Spes CH, Angermann CE. Stress echocardiography for assessment of cardiac allograft vasculopathy. Z Kardiol. 2000;89(suppl 9):IX/50-3.
39. Derumeaux G, Redonnet M, Mouton-Schleifer D, etal. Dobutamine stress echocardiography in orthotopic heart transplant recipients. VACOMED Research Group. J Am Coll Cardiol. 1995;25:1665-1672.
40. Dipchand AI, Bharat W, Manlhiot C, Safi M, Lobach NE, McCrindle BW. A prospective study of dobutamine stress echocardiography for the assessment of cardiac allograft vasculopathy in pediatric heart transplant recipients. Pediatr Transplant. 2008;12:570-576.
41. Larsen RL, Applegate PM, Dyar DA, etal. Dobutamine stress echocardiography for assessing coronary artery disease after transplantation in children. J Am Coll Cardiol. 1998;32:515-520.
42. Sharples LD, Jackson CH, Parameshwar J, Wallwork J, Large SR. Diagnostic accuracy of coronary angiography and risk factors for post-heart-transplant cardiac allograft vasculopathy. Transplantation. 2003;76:679-682.
43. Gao SZ, Alderman EL, Schroeder JS, Silverman JF, Hunt SA. Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings. J Am Coll Cardiol. 1988;12:334-340.
44. Mehra MR, Crespo-Leiro MG, Dipchand A, etal. International society for heart and lung transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010. J Heart Lung Transplant. 2010;29:717-727.
45. Aiyagari R, Nika M, Gurney JG, etal. Association of pediatric heart transplant coronary vasculopathy with abnormal hemodynamic measures. Congenit Heart Dis. 2011;6:128-133.
46. Law Y, Boyle G, Miller S, etal. Restrictive hemodynamics are present at the time of diagnosis of allograft coronary artery disease in children. Pediatr Transplant. 2006;10:948-952.
47. Doucette JW, Corl PD, Payne HM, etal. Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity. Circulation. 1992;85:1899-1911.
48. Hamaoka K, Onouchi Z, Ohmochi Y, Sakata K. Coronary arterial flow-velocity dynamics in children with angiographically normal coronary arteries. Circulation. 1995;92:2457-2462.
49. Schubert S, Abdul-Khaliq H, Wellnhofer E, etal. Coronary flow reserve measurement detects transplant coronary artery disease in pediatric heart transplant patients. J Heart Lung Transplant. 2008;27:514-521.
50. Ogawa S, Ohkubo T, Fukazawa R, etal. Estimation of myocardial hemodynamics before and after intervention in children with Kawasaki disease. J Am Coll Cardiol. 2004;43:653-661.
51. Hamaoka K, Onouchi Z, Kamiya Y, Sakata K. Evaluation of coronary flow velocity dynamics and flow reserve in patients with Kawasaki disease by means of a Doppler guide wire. J Am Coll Cardiol. 1998;31:833-840.
52. Kuhn MA, Jutzy KR, Deming DD, etal. The medium-term findings in coronary arteries by intravascular ultrasound in infants and children after heart transplantation. J Am Coll Cardiol. 2000;36:250-254.
53. Schiele F, Meneveau N, Seronde MF, etal. Medical costs of intravascular ultrasound optimization of stent deployment. Results of the multicenter randomized "REStenosis after Intravascular ultrasound STenting" (RESIST) study. Int J Cardiovasc Intervent. 2000;3:207-213.
54. Alfonso F, Flores A, Escaned J, etal. Pressure wire kinking, entanglement, and entrapment during intravascular ultrasound studies: a potentially dangerous complication. Catheter Cardiovasc Interv. 2000;50:221-225.
55. Costello JM, Wax DF, Binns HJ, Backer CL, Mavroudis C, Pahl E. A comparison of intravascular ultrasound with coronary angiography for evaluation of transplant coronary disease in pediatric heart transplant recipients. J Heart Lung Transplant. 2003;22:44-49.
56. Kobashigawa JA, Tobis JM, Starling RC, etal. Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years. J Am Coll Cardiol. 2005;45:1532-1537.
57. Rickenbacher PR, Pinto FJ, Lewis NP, etal. Prognostic importance of intimal thickness as measured by intracoronary ultrasound after cardiac transplantation. Circulation. 1995;92:3445-3452.
58. Lu WH, Palatnik K, Fishbein GA, etal. Diverse morphologic manifestations of cardiac allograft vasculopathy: a pathologic study of 64 allograft hearts. J Heart Lung Transplant. 2011;30:1044-1050.
59. van Loosdregt J, van Oosterhout MF, Bruggink AH, etal. The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response. Circulation. 2006;114:1599-1607.
60. Bae KT, Hong C, Takahashi N, etal. Multi-detector row computed tomographic angiography in pediatric heart transplant recipients: initial observations. Transplantation. 2004;77:599-602.
61. Gaemperli O, Kaufmann PA. PET and PET/CT in cardiovascular disease. Ann N Y Acad Sci. 2011;1228:109-136.
62. Wu YW, Chen YH, Wang SS, etal. PET assessment of myocardial perfusion reserve inversely correlates with intravascular ultrasound findings in angiographically normal cardiac transplant recipients. J Nucl Med. 2010;51:906-912.
63. Hussain TG, Greil G, Taylor A, etal. Detection and grading of coronary allograft vasculopathy in children using late gadolinium enhancement MRI. J Heart Lung Transplant. 2011;30:S133-S134.